NEW YORK (AP) — NEW YORK (AP) — Immunic, Inc. (IMUX) on Thursday reported a loss of $24.4 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 24 cents.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX